Literature DB >> 12882177

The role of C-reactive protein in the evaluation and management of infants with suspected sepsis.

Joan M Hengst1.   

Abstract

C-reactive protein (CRP) is a nonspecific, acute-phase protein that rises in response to infectious and noninfectious inflammatory processes. Good evidence exists to support the use of CRP measurements in conjunction with other established diagnostic tests (such as a white blood cell (WBC) count with differential and blood culture) to establish or exclude the diagnosis of sepsis in full-term or near-term infants. This article reviews the immunologic function of CRP and the history of CRP testing. The 3 methods for measuring CRP and the sensitivity and specificity of this diagnostic test are analyzed. Guidelines for the use of CRP in the evaluation and management of infants with suspected sepsis are presented. Quantitative serial CRP levels, obtained 24 hours after the onset of signs and symptoms of infection, with serial measurements 12 to 24 hours apart, offer the most sensitive and reliable information. At least 2 CRP levels, obtained 24 hours apart, with levels < or = 10 mg/L, are needed to identify infants unlikely to be infected. The use of CRP to exclude infection may allow clinicians to discontinue antibiotics at 48 hours in select infants, limiting extended unnecessary antibiotic exposure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882177     DOI: 10.1053/adnc.2003.50010

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  20 in total

1.  [Unifying criteria for late neonatal sepsis: proposal for an algorithm of diagnostic surveillance].

Authors:  Alonso Zea-Vera; Christie G Turin; Theresa J Ochoa
Journal:  Rev Peru Med Exp Salud Publica       Date:  2014-04

2.  Normal Ranges for Acute Phase Reactants (Interleukin-6, Tumour Necrosis Factor-alpha and C-reactive Protein) in Umbilical Cord Blood of Healthy Term Neonates at the Mount Hope Women's Hospital, Trinidad.

Authors:  A Khan; Z Ali
Journal:  West Indian Med J       Date:  2014-06-11       Impact factor: 0.171

3.  Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial.

Authors:  N B Mathur; A Murugesan
Journal:  Indian J Pediatr       Date:  2018-05-21       Impact factor: 1.967

4.  C-Reactive Protein, Detected with a Highly Sensitive Assay, in Non-Infected Newborns and Those with Early Onset Infection.

Authors:  Melanie Muenzenmaier; Marita Depperschmid; Christian Gille; Christian F Poets; Thorsten W Orlikowsky
Journal:  Transfus Med Hemother       Date:  2008-01-15       Impact factor: 3.747

5.  Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants.

Authors:  Elvira Parravicini; Sheri L Nemerofsky; Kenneth A Michelson; Trang K Huynh; Meghan E Sise; David A Bateman; John M Lorenz; Jonathan M Barasch
Journal:  Pediatr Res       Date:  2010-06       Impact factor: 3.756

Review 6.  Neonatal infectious diseases: evaluation of neonatal sepsis.

Authors:  Andres Camacho-Gonzalez; Paul W Spearman; Barbara J Stoll
Journal:  Pediatr Clin North Am       Date:  2013-01-17       Impact factor: 3.278

7.  C-reactive protein collaborates with plasma lectins to boost immune response against bacteria.

Authors:  Patricia M L Ng; Agnès Le Saux; Chia M Lee; Nguan S Tan; Jinhua Lu; Steffen Thiel; Bow Ho; Jeak L Ding
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

8.  C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.

Authors:  Yael Paran; Doron Yablecovitch; Guy Choshen; Ina Zeitlin; Ori Rogowski; Ronen Ben-Ami; Michal Katzir; Hila Saranga; Tovit Rosenzweig; Dan Justo; Yaffa Orbach; Pinhas Halpern; Shlomo Berliner
Journal:  Crit Care       Date:  2009-04-08       Impact factor: 9.097

Review 9.  Aptamer-based biosensors for the diagnosis of sepsis.

Authors:  Lubin Liu; Zeyu Han; Fei An; Xuening Gong; Chenguang Zhao; Weiping Zheng; Li Mei; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2021-07-19       Impact factor: 10.435

10.  Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L).

Authors:  Mei-Yin Lai; Ming-Horng Tsai; Chiang-Wen Lee; Ming-Chou Chiang; Reyin Lien; Ren-Huei Fu; Hsuan-Rong Huang; Shih-Ming Chu; Jen-Fu Hsu
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.